Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 1 Trials for Cediranib (DB04849)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | Treatment |